Preeclampsia is a life-threatening hypertensive disorder, affecting 2%–5% of pregnancies, that remains poorly understood. In a recent study published by Physiological Genomics that was partially funded by the Preeclampsia Foundation's...
Echocardiography, commonly referred to as cardiac ultrasound or an “echo”, generates visual images of the heart known as echocardiograms. This imaging technique is especially informative during the peripartum period, the time encompassing...
There is an increased cardiovascular risk after a pregnant woman has preeclampsia. Previous research found that there are signs of early cardiovascular aging when a woman is six months postpartum. This study looked at women when they were six mo...
The accuracy of medical history is critical for the care of any patient. Preeclampsia increases the risk of complications in future pregnancies and is also associated with an increased risk of cardiovascular disease (CVD). The ability of patients to...
The authors of this paper note that an increasing number of people are being readmitted to the hospital within six weeks of discharge home after delivery and that many of these persons had a hypertensive disorder of pregnancy (HDP). Utilizing data fr...
This study aimed to examine the performance of two algorithms for diagnosis of hypertensive disorders of pregnancy (HDP) with medical record data from a large cohort of pregnant women. In this article, the researchers emphasize the importan...
A recent meta-analysis of 130 preeclampsia prevention trials found some successful strategies but demonstrated the need for more research.
Self-monitoring of blood pressure outside the doctor’s office may help identify women with masked hypertension during pregnancy.
Research study suggests that planned delivery at term (37 weeks) may be an intervention worthy of consideration in women at high-risk for preeclampsia.
This study looked at whether a genome wide analysis study could identify and use maternal DNA variation to predict preeclampsia and gestational hypertension.
This study looked at whether messenger RNA markers in the blood stream could help identify patients at risk of developing preterm or early-onset preeclampsia.
Based on limited data, pravastatin use during pregnancy does not appear to have any long-term adverse effects on children. his information will be useful for gaining approval for larger studies to see if pravastatin is actually useful in preventing...